• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对HIV-1进入抑制的动力学依赖性。

Kinetic dependence to HIV-1 entry inhibition.

作者信息

Steger H Kirby, Root Michael J

机构信息

Department of Biochemistry and Molecular Biology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.

出版信息

J Biol Chem. 2006 Sep 1;281(35):25813-21. doi: 10.1074/jbc.M601457200. Epub 2006 Jun 27.

DOI:10.1074/jbc.M601457200
PMID:16803885
Abstract

Infection by human immunodeficiency virus type 1 (HIV-1) involves the fusion of viral and cellular membranes mediated by formation of the gp41 trimer-of-hairpins. A designed protein, 5-Helix, targets the C-terminal region of the gp41 ectodomain, disrupting trimer-of-hairpins formation and blocking viral entry. Here we show that the nanomolar inhibitory potency of 5-Helix (IC50 approximately 6 nm) is 4 orders of magnitude larger than its subpicomolar binding affinity (K(D) approximately 0.6 pm). This discrepancy results from the transient exposure of the 5-Helix binding site on gp41. As a consequence, inhibitory potency is determined by the association rate, not by binding affinity. For a series of 5-Helix variants with mutations in their gp41 binding sites, the IC50 and K(D) values poorly correlate. By contrast, an inverse relationship between IC50 values and association rate constants (k(on)) extends for over 2 orders of magnitude. The kinetic dependence to inhibition places temporal restrictions on an intermediate state of HIV-1 membrane fusion and suggests that access to the C-terminal region of the gp41 ectodomain is largely free from steric hindrance. Our results support the importance of association kinetics in the development of improved HIV-1 fusion inhibitors.

摘要

1型人类免疫缺陷病毒(HIV-1)感染涉及由gp41发夹三聚体形成介导的病毒膜与细胞膜的融合。一种设计蛋白5-Helix靶向gp41胞外结构域的C末端区域,破坏发夹三聚体的形成并阻断病毒进入。我们在此表明,5-Helix的纳摩尔抑制效力(IC50约为6 nM)比其亚皮摩尔结合亲和力(K(D)约为0.6 pM)大4个数量级。这种差异源于gp41上5-Helix结合位点的短暂暴露。因此,抑制效力由缔合速率决定,而非结合亲和力。对于一系列在其gp41结合位点发生突变的5-Helix变体,IC50和K(D)值相关性较差。相比之下,IC50值与缔合速率常数(k(on))之间的反比关系延伸超过2个数量级。抑制的动力学依赖性对HIV-1膜融合的中间状态施加了时间限制,并表明接近gp41胞外结构域的C末端区域在很大程度上不受空间位阻的影响。我们的结果支持缔合动力学在改进HIV-1融合抑制剂开发中的重要性。

相似文献

1
Kinetic dependence to HIV-1 entry inhibition.对HIV-1进入抑制的动力学依赖性。
J Biol Chem. 2006 Sep 1;281(35):25813-21. doi: 10.1074/jbc.M601457200. Epub 2006 Jun 27.
2
Efficient Fusion at Neutral pH by Human Immunodeficiency Virus gp41 Trimers Containing the Fusion Peptide and Transmembrane Domains.含融合肽和跨膜结构域的人类免疫缺陷病毒gp41三聚体在中性pH下的高效融合
Biochemistry. 2018 Feb 20;57(7):1219-1235. doi: 10.1021/acs.biochem.7b00753. Epub 2018 Feb 6.
3
Design and properties of N(CCG)-gp41, a chimeric gp41 molecule with nanomolar HIV fusion inhibitory activity.具有纳摩尔级HIV融合抑制活性的嵌合gp41分子N(CCG)-gp41的设计与特性
J Biol Chem. 2001 Aug 3;276(31):29485-9. doi: 10.1074/jbc.C100317200. Epub 2001 Jun 19.
4
The fusion activity of HIV-1 gp41 depends on interhelical interactions.HIV-1 gp41的融合活性取决于螺旋间的相互作用。
J Biol Chem. 2005 May 20;280(20):19852-7. doi: 10.1074/jbc.M502196200. Epub 2005 Mar 16.
5
Membrane-anchored inhibitory peptides capture human immunodeficiency virus type 1 gp41 conformations that engage the target membrane prior to fusion.膜锚定抑制性肽捕获人类免疫缺陷病毒1型gp41在融合前与靶膜结合的构象。
J Virol. 2006 Apr;80(7):3249-58. doi: 10.1128/JVI.80.7.3249-3258.2006.
6
Steric accessibility of the HIV-1 gp41 N-trimer region.HIV-1 gp41 N-三聚体区域的空间可及性。
J Biol Chem. 2005 Apr 1;280(13):12567-72. doi: 10.1074/jbc.M412770200. Epub 2005 Jan 18.
7
The prefusogenic intermediate of HIV-1 gp41 contains exposed C-peptide regions.HIV-1 gp41的融合前中间体包含暴露的C肽区域。
J Biol Chem. 2003 Feb 28;278(9):7573-9. doi: 10.1074/jbc.M211154200. Epub 2002 Dec 13.
8
Interhelical interactions in the gp41 core: implications for activation of HIV-1 membrane fusion.gp41核心中的螺旋间相互作用:对HIV-1膜融合激活的影响。
Biochemistry. 2002 Jun 11;41(23):7283-92. doi: 10.1021/bi025648y.
9
Protein design of an HIV-1 entry inhibitor.一种HIV-1进入抑制剂的蛋白质设计。
Science. 2001 Feb 2;291(5505):884-8. doi: 10.1126/science.1057453.
10
Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.HIV-1 gp41 衣壳蛋白 C 端七肽重复区的保守残基 Asn-145 对病毒融合至关重要,并调节融合抑制剂的抗病毒活性。
Viruses. 2019 Jul 3;11(7):609. doi: 10.3390/v11070609.

引用本文的文献

1
Structure and Interactions of HIV-1 gp41 CHR-NHR Reverse Hairpin Constructs Reveal Molecular Determinants of Antiviral Activity.HIV-1 gp41 CHR-NHR 反向发夹结构与相互作用揭示了抗病毒活性的分子决定因素。
J Mol Biol. 2024 Aug 15;436(16):168650. doi: 10.1016/j.jmb.2024.168650. Epub 2024 Jun 10.
2
HIV-1 prehairpin intermediate inhibitors show efficacy independent of neutralization tier.HIV-1 发夹前中间体抑制剂的疗效不依赖中和作用。
Proc Natl Acad Sci U S A. 2023 Feb 21;120(8):e2215792120. doi: 10.1073/pnas.2215792120. Epub 2023 Feb 16.
3
Exploring Highly Conserved Regions of SARS-CoV-2 Spike S2 Subunit as Targets for Fusion Inhibition Using Chimeric Proteins.
探索 SARS-CoV-2 刺突 S2 亚基的高度保守区域,使用嵌合蛋白作为融合抑制的靶点。
Int J Mol Sci. 2022 Dec 7;23(24):15511. doi: 10.3390/ijms232415511.
4
Regulation of epitope exposure in the gp41 membrane-proximal external region through interactions at the apex of HIV-1 Env.通过 HIV-1 包膜蛋白Env 顶点的相互作用调节 gp41 膜近端外部区的表位暴露。
PLoS Pathog. 2022 May 18;18(5):e1010531. doi: 10.1371/journal.ppat.1010531. eCollection 2022 May.
5
Conformational Stabilization of Gp41-Mimetic Miniproteins Opens Up New Ways of Inhibiting HIV-1 Fusion.构象稳定的 Gp41 模拟型小蛋白为抑制 HIV-1 融合开辟了新途径。
Int J Mol Sci. 2022 Mar 3;23(5):2794. doi: 10.3390/ijms23052794.
6
Extremely Thermostabilizing Core Mutations in Coiled-Coil Mimetic Proteins of HIV-1 gp41 Produce Diverse Effects on Target Binding but Do Not Affect Their Inhibitory Activity.极度热稳定核心突变在 HIV-1 gp41 的卷曲螺旋模拟蛋白中产生对靶标结合的不同影响,但不影响其抑制活性。
Biomolecules. 2021 Apr 12;11(4):566. doi: 10.3390/biom11040566.
7
Characterization of resistance to a potent D-peptide HIV entry inhibitor.耐药性对强效 D-肽 HIV 进入抑制剂的影响。
Retrovirology. 2019 Oct 22;16(1):28. doi: 10.1186/s12977-019-0489-7.
8
Strain-Dependent Activation and Inhibition of Human Immunodeficiency Virus Entry by a Specific PF-68742 Stereoisomer.特定 PF-68742 立体异构体对人类免疫缺陷病毒进入的应变依赖性激活和抑制。
J Virol. 2019 Oct 15;93(21). doi: 10.1128/JVI.01197-19. Print 2019 Nov 1.
9
Molecular mechanism of HIV-1 resistance to sifuvirtide, a clinical trial-approved membrane fusion inhibitor.HIV-1 对司非韦仑耐药的分子机制,司非韦仑是一种临床试验批准的膜融合抑制剂。
J Biol Chem. 2018 Aug 17;293(33):12703-12718. doi: 10.1074/jbc.RA118.003538. Epub 2018 Jun 21.
10
Reduced Susceptibility to VIRIP-Based HIV-1 Entry Inhibitors Has a High Genetic Barrier and Severe Fitness Costs.对基于 VIRIP 的 HIV-1 进入抑制剂的敏感性降低具有较高的遗传屏障和严重的适应性成本。
J Virol. 2018 Aug 16;92(17). doi: 10.1128/JVI.00733-18. Print 2018 Sep 1.